Characterization of thioredoxin glutathione reductase in Schiotosoma japonicum

Parasitology International

Volumn 61, Issue 3, 2012, Pages 475-480

  Han, Yanhui ^a,b   Zhang, Min ^a   Hong, Yang ^a   Zhu, Zhu ^a   Li, Dong ^a   Li, Xiangrui ^b   Fu, Zhiqiang ^a   Lin, Jiaojiao ^a  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Clone; Schistosoma japonicum; Thioredoxin glutathione reductase; Vaccine

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); COMPLEMENTARY DNA; GAMMA INTERFERON; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4; THIOREDOXIN GLUTATHIONE REDUCTASE; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASE PAIRING; BIOLOGICAL FUNCTIONS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; IMMUNOGENICITY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PARASITE IDENTIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHISTOSOMA JAPONICUM; SPLEEN CELL; VACCINATION; WORM INFECTION;

ANIMALS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DNA, HELMINTH; ESCHERICHIA COLI; FEMALE; HELMINTH PROTEINS; MALE; MICE; MICE, INBRED BALB C; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SEQUENCE ANALYSIS, DNA; VACCINATION;

ESCHERICHIA COLI; MUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 84861482524     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2012.03.005     Document Type: Article

References (22)

1. Lopes D.O., Paiva L.F., Martins M.A., Cardoso F.C., Rajao M.A., Pinho J.M., et al. Sm21.6 a novel EF-hand family protein member located on the surface of Schistosoma mansoni adult worm that failed to induce protection against challenge infection but reduced liver pathology. Vaccine Jun 24 2009, 27(31):4127-4135.
2. Cioli D., Valle C., Angelucci F., Miele A.E. Will new antischistosomal drugs finally emerge?. Trends in Parasitology Sep 2008, 24(9):379-382.
3. Fenwick A., Savioli L., Engels D., Robert Bergquist N., Todd M.H. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends in Parasitology Nov 2003, 19(11):509-515.
4. Bergquist N.R. Schistosomiasis vaccine development: progress and prospects. Memórias do Instituto Oswaldo Cruz 1998, 93(Suppl. 1):95-101.
5. Bergquist N.R. Schistosomiasis: from risk assessment to control. Trends in Parasitology Jul 2002, 18(7):309-314.
6. Chitsulo L., Loverde P., Engels D. Schistosomiasis. Nature Reviews Microbiology Jan 2004, 2(1):12-13.
7. Alger H.M., Williams D.L. The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase. Molecular and Biochemical Parasitology Apr 30 2002, 121(1):129-139.
8. Kuntz A.N., Davioud-Charvet E., Sayed A.A., Califf L.L., Dessolin J., Arner E.S., et al. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Medicine Jun 2007, 4(6):e206.
9. Alger H.M., Sayed A.A., Stadecker M.J., Williams D.L. Molecular and enzymatic characterisation of Schistosoma mansoni thioredoxin. International Journal of Parasitology Sep 2002, 32(10):1285-1292.
10. Xie S.Y., Yin X.Y., Hua W.Q., Zeng X.J., Chen H.G., Liang Y.S., et al. Cloning and sequence analysis of thioredoxin glutathione reductase gene of Schistosoma japonicum. Chinese Journal of Schistosomiasis Control 2008, 6(20):427-430.
11. Kumagai T., Osada Y., Ohta N., Kanazawa T. Peroxiredoxin-1 from Schistosoma japonicum functions as a scavenger against hydrogen peroxide but not nitric oxide. Molecular and Biochemical Parasitology Mar 2009, 164(1):26-31.
12. Arner E.S., Sarioglu H., Lottspeich F., Holmgren A., Bock A. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes. Journal of Molecular Biology Oct 8 1999, 292(5):1003-1016.
13. Cardoso L.S., Araujo M.I., Goes A.M., Pacifico L.G., Oliveira R.R., Oliveira S.C. Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microbial Cell Factories 2007, 6:1.
14. Fonseca C.T., Brito C.F., Alves J.B., Oliveira S.C. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine Jan 2 2004, 22(3-4):503-510.
15. Pacifico L.G., Fonseca C.T., Chiari L., Oliveira S.C. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine. Immunobiology 2006, 211(1-2):97-104.
16. Wu Z.D., Lu Z.Y., Yu X.B. Development of a vaccine against Schistosoma japonicum in China: a review. Acta Tropica Nov-Dec 2005, 96(2-3):106-116.
17. Sher A., Coffman R.L., Hieny S., Scott P., Cheever A.W. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(1):61-65.
18. Hewitson J.P., Hamblin P.A., Mountford A.P. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunology 2005, 27(7-8):271-280.
19. Smythies L.E., Coulson P.S., Wilson R.A. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. Journal of Immunology 1992, 149(11):3654-3658.
20. Wilson R.A., Coulson P.S., Betts C., Dowling M.A., Smythies L.E. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 1996, 87(2):275-282.
21. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin C.P., Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nature Medicine 2008, 14(4):407-412.
22. Pushpamali W.A., De Zoysa M., Kang H.S., Oh C.H., Whang I., Kim S.J., et al. Comparative study of two thioredoxin peroxidases from disk abalone (Haliotis discus discus): cloning, recombinant protein purification, characterization of antioxidant activities and expression analysis. Fish & Shellfish Immunology 2008, 24(3):294-307.